An in-depth look to ASCENDIS PHARMA A/S operating, investing, and financing activities

ASND/N free cash flow for Q3 24 is -1.22 B MXN. For 2023, ASND/N free cash flow was -8.63 B MXN and operating cash flow was -8.58 B MXN.